Loading institutional data...
Loading institutional data...
Held by 752 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $15.13 today, the market must believe free cash flow compounds -1.3%/yr for a decade (off $1.3B normalized FCF).
The market's -1.3% is more conservative than its 9-yr track record.
2-stage DCF · 0.48B shares (market data) · net debt $6.3B
mean 13.0% · volatility σ 66% · implied rate exceeded in 3/9 yrs
Central path = implied -1.3%/yr growth; shaded band = ±1σ (66%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 68% of free cash flow, leaving room to grow it and fund buybacks. Last year: $670M dividends + $15M buybacks = $685M returned on $979M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -15%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $218M is below the $779M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2026-05-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $218M fully covers short-term debt of $34M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-18
No standout strengths flagged.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 76.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 72.2 | 72.2 | 71.6 | 75.4 | 73.4 | 72.3 | 74.1 | 76.1 |
| Gross Profit | — | — | — | — | 26.6 | 27.7 | 25.9 | 23.9 |
| R&D | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 |
| SG&A | 15.4 | 14.7 | 12.5 | 12.9 | 11.7 | 12.3 | 13.2 | 12.8 |
| Operating Income | 17.2 | 16.4 | 19.1 | 13.8 | 8.8 | 7.1 | 11.8 | -14.4 |
| Income Tax | 2.3 | 1.8 | 1.7 | 2.5 | 1.8 | 2.2 | 0.0 | 0.8 |
| Net Income | 7.1 | 7.6 | 11.6 | 7.7 | 5.6 | 2.9 | 9.9 | -17.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CAG: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-18
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.28B 100.0% | $11.61B 100.0% | $12.05B 100.0% | $12.28B 100.0% | $11.54B 100.0% | $11.18B 100.0% | $11.05B 100.0% | $9.54B 100.0% | $7.94B 100.0% | $7.83B 100.0% |
| Cost of Revenue | $8.58B 76.1% | $8.61B 74.1% | $8.72B 72.3% | $9.01B 73.4% | $8.70B 75.4% | $8.01B 71.6% | $7.98B 72.2% | $6.89B 72.2% | $5.59B 70.4% | $5.48B 70.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $5.59B 70.4% | $5.48B 70.1% |
| Gross Profit | $2.70B 23.9% | $3.00B 25.9% | $3.33B 27.7% | $3.26B 26.6% | — | — | — | — | — | — |
| Research & Development | $62.7M 0.6% | $60.8M 0.5% | $61.4M 0.5% | $57.7M 0.5% | $53.4M 0.5% | $51.3M 0.5% | $56.4M 0.5% | $56.1M 0.6% | $47.3M 0.6% | $44.6M 0.6% |
| Selling, General & Admin | $1.44B 12.8% | $1.54B 13.2% | $1.49B 12.3% | $1.43B 11.7% | $1.49B 12.9% | $1.40B 12.5% | $1.62B 14.7% | $1.47B 15.4% | $1.40B 17.6% | $1.47B 18.8% |
| Operating Income | -$1.63B -14.4% | $1.36B 11.8% | $852.8M 7.1% | $1.08B 8.8% | $1.59B 13.8% | $2.14B 19.1% | $1.82B 16.4% | $1.64B 17.2% | $1.41B 17.8% | $1.24B 15.8% |
| Interest & Investment Income | $7.5M 0.1% | $2.5M 0.0% | $5.7M 0.0% | $3.9M 0.0% | $2.1M 0.0% | $1.9M 0.0% | $3.1M 0.0% | $6.8M 0.1% | $3.8M 0.0% | $3.7M 0.0% |
| Pretax Income | -$1.82B -16.2% | $1.16B 10.0% | $610.2M 5.1% | $901.9M 7.3% | $1.18B 10.2% | $1.49B 13.4% | $1.04B 9.4% | $899.1M 9.4% | $972.1M 12.2% | $800.7M 10.2% |
| Income Tax Expense | $91.8M 0.8% | $3.7M 0.0% | $262.5M 2.2% | $218.7M 1.8% | $290.5M 2.5% | $193.8M 1.7% | $201.3M 1.8% | $218.8M 2.3% | $174.6M 2.2% | $254.7M 3.3% |
| Net Income | -$1.92B -17.0% | $1.15B 9.9% | $347.7M 2.9% | $683.2M 5.6% | $888.2M 7.7% | $1.30B 11.6% | $840.1M 7.6% | $678.3M 7.1% | $808.4M 10.2% | $639.3M 8.2% |
| Per Share | ||||||||||
| EPS (Basic) | $-4.00 | $2.41 | $0.73 | $1.43 | $1.85 | $2.67 | $1.72 | $1.53 | $2.00 | $1.48 |
| EPS (Diluted) | $-4.00 | $2.40 | $0.72 | $1.42 | $1.84 | $2.66 | $1.72 | $1.52 | $1.98 | $1.46 |
| Weighted Avg Shares (Basic) | 479.0M | 478.3M | 478.6M | 478.9M | 480.3M | 485.8M | 487.3M | 444.0M | 403.9M | 431.9M |
| Weighted Avg Shares (Diluted) | 479.0M | 479.7M | 480.0M | 480.7M | 482.2M | 487.8M | 488.6M | 445.6M | 407.4M | 436.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.0B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.8B | 49.2× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $379.7B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $344.0B | 22.5× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $293.5B | 26.0× | 17.1× | 7.2× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $177.6B | 21.6× | 14.6× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.4B | 16.9× | 13.5× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $78.7B | 32.2× | 18.5× | 2.0× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $71.6B | 19.5× | 10.4× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.1B | 33.3× | 19.5× | 3.4× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.7B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.1B | 20.2× | 14.2× | 2.5× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $41.2B | 38.2× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $40.4B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.3B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.1B | 39.0× | 9.9× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| HSY | $34.4B | — | 20.2× | 3.0× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| KVUE | $34.1B | 23.4× | 11.6× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| EL | $33.6B | — | 764.7× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.5B | 16.1× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $28.9B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.0B | 17.9× | 7.9× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.1B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.0B | 31.4× | 18.7× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
| CAG | $7.3B | — | — | 0.6× | -2.9% | 23.9% | -17.0% | -30.1% | -14.9% | -5.3× | 752 |
Peers = companies sharing CAG's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.